Biaffin

Newsletter

kinases protein kinase inhibitors signaling activators kinase substrates antibodies bioluminescence assays
Recombinant human FGFR1 /CD331 Protein, His tag, 200µg  

Recombinant human FGFR1 /CD331 Protein, His tag, 200µg

Recombinant Human FGFR1 /CD331 Protein, Arg22-Ile376, expressed in human 293 cells (HEK293), His tag

Synonym
Recombinant Human Protein, FGFR1, FGFR-1, BFGFR, CD331, CEK, FGFBR, FLG, HBGFR, N-SAM, FLT2, Fibroblast Growth Factor Receptor 1

More details

FG1-H5223-200

Availability: within 7 days

420,00 €

Background
Fibroblast growth factor receptor 1 (FGFR1) is also known as basic fibroblast growth factor receptor 1(BFGFR1), FMS-like tyrosine kinase, CD331, and is a receptor tyrosine kinase whose ligands are specific members of the fibroblast growth factor family. This protein is one of several fibroblast growth factor receptors, which are related proteins that are involved in important processes such as cell division, regulation of cell growth and maturation, formation of blood vessels, wound healing, and embryonic development.The FGFR1 protein spans the cell membrane, so that one end of the protein remains inside the cell and the other end projects from the outer surface of the cell. This positioning allows the FGFR1 protein to interact with specific growth factors outside the cell and to receive signals that help the cell respond to its environment. When growth factors attach to the FGFR1 protein, the receptor triggers a cascade of chemical reactions inside the cell that instruct the cell to undergo certain changes, such as maturing to take on specialized functions. The FGFR1 protein is thought to play an important role in the development of the nervous system. This protein may also help regulate the growth of long bones, such as the large bones in the arms and legs [1-2].

Source
Recombinant Human FGFR1 /CD331 Protein (rhFGFR1) Arg22-Ile376 (Accession # AAH18128) expressed in human 293 cells (HEK293)

Molecular Characterization
This protein carries a polyhistidine tag at the C-terminus. The protein has a calculated MW of 42.5 kDa. The protein migrates as 60-90 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

Endotoxin
Less than 1.0 EU per μg of the protein by LAL method.

Purity
>95% as determined by SDS-PAGE.

Formulation
Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally Mannitol or Trehalose are added as protectants before lyophilization.

Reconstitution
See Certificate of Analysis for details of reconstitution instruction and specific concentration.

Storage
Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at:
In lyophilized state for 1 year (4°C-8°C); After reconstitution under sterile conditions for 1 month (4°C-8°C) or 3 months (-20°C to -70°C).

References

(1) Elbauomy Elsheikh S,et al., 2007, Breast Cancer Res.,9(2):R23
(2) Macdonald D,et al., 2002, Acta Haematol. 107(2):101-7

The following products could also be interesting for you: